Pérez-Crespo M, Silvestre J F, Lucas A, Mataix J, Ballester I
Sección de Dermatología, Hospital General Universitario de Alicante, España.
Actas Dermosifiliogr. 2009 May;100(4):291-7.
Corticosteroid contact dermatitis and its patch testing are subject to certain peculiarities that we should be aware of.
We performed a retrospective study of all patients who underwent patch tests with a corticosteroid battery in the Skin Allergy Unit of the Dermatology Department of Hospital General Universitario, Alicante, Spain, between October 2004 and June 2007.
During the study period, patch tests were performed on 1065 patients in our allergy unit. A corticosteroid battery was used in 34 patients (3.1 %). Fourteen patients were positive for budesonide or tixocortol in the standard battery; 20 were negative for these allergens but there was a clinical suspicion of steroid allergy. At least one positive reaction in the corticosteroid battery was observed in 15 patients (44.1 %). The substance most commonly implicated was budesonide (13 patients sensitized). The corticosteroid battery revealed sensitization to other groups of corticosteroids in 4 of the 15 patients with corticosteroid sensitization. Seventeen patients brought drugs that were also tested, obtaining positive results for 10 substances.
Allergens for contact dermatitis due to corticosteroids included in the standard battery (budesonide and tixocortol) detected 93 % of patients who are sensitized to steroids; there would appear to be little benefit in performing a corticosteroid battery if those markers are negative. The battery of corticosteroids and the drugs provided by patients were useful to define more exactly the corticosteroid classes that the patient should avoid.
皮质类固醇接触性皮炎及其斑贴试验存在一些我们应当了解的特殊情况。
我们对2004年10月至2007年6月期间在西班牙阿利坎特大学综合医院皮肤科皮肤过敏科接受皮质类固醇系列斑贴试验的所有患者进行了一项回顾性研究。
在研究期间,我们过敏科对1065例患者进行了斑贴试验。34例患者(3.1%)使用了皮质类固醇系列。标准系列中14例患者布地奈德或丁氯倍他松呈阳性;20例患者这些过敏原呈阴性,但临床上怀疑有类固醇过敏。15例患者(44.1%)在皮质类固醇系列中观察到至少一种阳性反应。最常涉及的物质是布地奈德(13例致敏)。在15例皮质类固醇致敏患者中的4例,皮质类固醇系列显示对其他皮质类固醇组致敏。17例患者带来了所服用的药物并进行了检测,10种物质检测结果呈阳性。
标准系列(布地奈德和丁氯倍他松)中包含的皮质类固醇引起接触性皮炎的过敏原检测出了93%对类固醇致敏的患者;如果这些指标为阴性,进行皮质类固醇系列检测似乎益处不大。皮质类固醇系列和患者提供的药物有助于更准确地确定患者应避免使用的皮质类固醇类别。